Riskpilot← Back to searchSign inGet full accessGRØNTVEDT BIOTECH AS
ASActiveOrg 929957199Havneveien 1, 7142 UthaugManufacture of oils and fats · NACE 1041Est. 20224 employees
Revenue 2024
NOK 8,1M
+87% vs 2023
EBITDA margin
-115.1%
+1% vs 2023
Equity ratio
-126.5%
Financial strength
Net profit 2024
NOK -13,7M
+3% vs 2023
| Revenue | NOK 8,1M | +87% |
| EBITDA | NOK -9,3M | +1% |
| Net profit | NOK -13,7M | +3% |
| Total assets | NOK 10M | -78% |
| Equity | NOK -12,7M | -1293% |
| Employees | 4 | — |
Legal name
GRØNTVEDT BIOTECH AS
Org number
929957199
Legal form
Aksjeselskap
NACE code
1041 · Manufacture of oils and fats
Founded
29. september 2022
Share capital
NOK 1 000 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Produksjon av raffinerte oljer og fett, samt det som naturlig står i forbindelse med dette.
Address
Havneveien 1, 7142 Uthaug
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 888 | 4 321 | 8 089 |
| Staff expenses | −0 | −5 296 | −5 993 |
| EBITDA | −4 777 | −9 362 | −9 313 |
| Depreciation & amort. | −0 | −1 193 | −520 |
| EBIT | −4 777 | −10 555 | −9 834 |
| Net financials | 2 | −2 609 | −3 885 |
| Profit before tax | −4 775 | −13 163 | −13 718 |
| Tax | −1 051 | 1 051 | −0 |
| Net profit | −3 725 | −14 214 | −13 718 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 10 893 | 45 265 | 10 006 |
| Equity | −2 725 | 1 061 | −12 657 |
| Long-term debt | 0 | 13 818 | 0 |
| Short-term debt | 13 618 | 30 385 | 22 663 |
| Total debt | 13 618 | 44 204 | 22 663 |
EBITDA margin
-115.1%
This company
15.8%
Market median
-828% vs market
20222024
Equity ratio
-126.5%
This company
38.2%
Market median
-431% vs market
20222024
Return on equity
-1371844300.0%
This company
18.4%
Market median
-7455675643% vs market
20222024
Net profit margin
-169.6%
This company
8.1%
Market median
-2194% vs market
20222024
Asset turnover
0.81×
This company
1.12×
Market median
+28% vs market
20222024
Debt / equity
1.79×
This company
0.62×
Market median
-189% vs market
20222024
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Chairman | 2026 | |
| Board of Directors | 2026 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Chairman | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 92% | 92% | 2024 | |
| Company | 8% | 8% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tabio Holding As
GRØNTVEDT BIOTECH AS Board members of GRØNTVEDT BIOTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Otto Gregussen | Chairman | 0 companies |
| Henrik Traaholt | Board of Directors | 0 companies |
| Helge Gåsø | Chairman | 0 companies |
| Bjørnar Grøntvedt | Chairman | 0 companies |
| Ola Christian Olsen | Board of Directors | 0 companies |
| Runar Aakvik | Board of Directors | 0 companies |